Gene · 6530
Papers3,539
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,539
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drosophila melanogaster as a model for unraveling unique molecular features of epilepsy elicited by human GABA transporter 1 variants. | Front Neurosci | 2022 | 36741049 | PubTator, text mining | PubMed |
| Endocrine disorders and fertility and pregnancy: An update. | Front Endocrinol (Lausanne) | 2022 | 36733805 | PubTator, text mining | PubMed |
| Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms. | Front Oncol | 2022 | 36733351 | PubTator, text mining | PubMed |
| Astatine-211 based radionuclide therapy: Current clinical trial landscape. | Front Med (Lausanne) | 2022 | 36687417 | PubTator, text mining | PubMed |
| Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder. | Front Neurosci | 2022 | 36685234 | PubTator, text mining | PubMed |
| A Novel Mast Cell Stabilizer JM25-1 Rehabilitates Impaired Gut Barrier by Targeting the Corticotropin-Releasing Hormone Receptors. | Pharmaceuticals (Basel) | 2022 | 36678544 | PubTator, text mining | PubMed |
| Mechanism of Datura metel on sinus bradycardia based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36626429 | PubTator, text mining | PubMed |
| Akathisia after chronic usage of synthetic cathinones: A case study. | Front Psychiatry | 2022 | 36620653 | PubTator, text mining | PubMed |
| Netarsudil as an Adjunctive Therapy: Efficacy and Factors Contributing to a Favorable IOP-Lowering Effect. | J Ophthalmol | 2022 | 36620524 | PubTator, text mining | PubMed |
| Rescue of Misfolded Organic Cation Transporter 3 Variants. | Cells | 2022 | 36611832 | PubTator, text mining | PubMed |
Investigation of the Antibacterial, Anti-Biofilm, and Antioxidative Effect of Piper betle Leaf Extract against Bacillus gaemokensis MW067143 Isolated from Dental Caries, an In Vitro-In Silico Approach. | Microorganisms | 2022 | 36557738 | PubTator, text mining | PubMed |
| Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology. | Medicina (Kaunas) | 2022 | 36557005 | PubTator, text mining | PubMed |
| The Pitfall of Ganglioneuroblastoma-Nodular Diagnosis: Clinical and Imaging Considerations over a Rare Bifocal Sporadic Case. | Diagnostics (Basel) | 2022 | 36553228 | PubTator, text mining | PubMed |
| Development of Post-Stroke Cognitive and Depressive Disturbances: Associations with Neurohumoral Indices. | Curr Issues Mol Biol | 2022 | 36547090 | PubTator, text mining | PubMed |
| Miro1 R272Q disrupts mitochondrial calcium handling and neurotransmitter uptake in dopaminergic neurons. | Front Mol Neurosci | 2022 | 36533136 | PubTator, text mining | PubMed |
| Locus coeruleus integrity correlates with inhibitory functions of the fronto-subthalamic 'hyperdirect' pathway in Parkinson's disease. | Neuroimage Clin | 2022 | 36510410 | PubTator, text mining | PubMed |
| Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A Review. | Int J Mol Sci | 2022 | 36499434 | PubTator, text mining | PubMed |
| Pharmacological Characterization of Purified Full-Length Dopamine Transporter from Drosophila melanogaster. | Cells | 2022 | 36497070 | PubTator, text mining | PubMed |
| Current situation and progress of drugs for reducing intraocular pressure. | Ther Adv Chronic Dis | 2022 | 36479139 | PubTator, text mining | PubMed |
| Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. | Front Pharmacol | 2022 | 36467081 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6530/papers?page=21